Bloodwork question about phenylpiracetam. Baseline, four months in, and the numbers moved in a direction I did not expect.
What surprised me is how much of the perceived benefit was routine and attention rather than pharmacology.
If you need three other compounds to notice the first one, you have not tested the first one.
Vivid dreams are reported widely and are not in the label because there is not really a label.
Posting to be argued with, mainly.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison. Four months in on phenylpiracetam and it lines up.
Same here.
What is the first thing you would read if you were starting from zero?
I would take the narrow conclusion. Broad ones are more interesting and less true.
How long before you can reasonably say something is or is not doing anything? How long have you been on phenylpiracetam?
Log dose, time and sleep. Ten seconds a day and it turns the anecdote into something you can look at.
Stupid question: how do you know whether what is in the vial matches the label at all?
My rule, after years of this: if it cannot survive being written down with the numbers attached, it is marketing.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison. Vivid dreams was my main issue with phenylpiracetam too.
Read methods.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.